Raidium Expands AI Radiology Platform to U.S. Cancer Centers
PARIS & SAN FRANCISCO, July 16, 2026 Raidium has announced the U.S. launch of Raidium Read (R.Read), an AI-powered...
antimicrobial resistance
Advertisement
Trellis Raises $9M to Advance Calpurbatug Phase 2 Trial
REDWOOD CITY, Calif., July 16, 2026 Trellis Bioscience has secured $9 million in Series C financing to accelerate the...
FDA Accepts Shionogi’s sNDA for Fetroja in Pediatric Gram-Negative Infections
FLORHAM PARK, N.J., July 16, 2026 Shionogi Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted...
Saol Therapeutics Resubmits NDA for SL1009 in PDCD
ROSWELL, Ga., DUBLIN, Ireland & HAMILTON, Bermuda, July 7, 2026 Saol Therapeutics has announced the resubmission of its New...
Lakewood-Amedex Backs PASTEUR Act to Fight AMR Crisis
SARASOTA, Fla., July 7, 2026 Lakewood-Amedex Biotherapeutics has announced its support for the reintroduction of the bipartisan Pioneering Antimicrobial...
Advertisements
AdJane Validates OMV Vaccine Platform in Human Phase I Trial
DELFT, The Netherlands, June 30, 2026 AdJane, a clinical-stage vaccine platform company, has announced the publication of first-in-human Phase...
Telum Therapeutics Raises €18M Series A for AMR Program
SPAIN, July 1, 2026 Telum Therapeutics announced the successful completion of an €18 million Series A financing round to...
Armata Secures $2.5M DoD Funding for AP-SA02
LOS ANGELES, Calif. | June 23, 2026 Armata Pharmaceuticals has received an additional $2.5 million in non-dilutive funding from...
Acurx Pharmaceuticals Showcases DNA pol IIIC Antibiotic Breakthrough
STATEN ISLAND, N.Y., June 16, 2026 Acurx Pharmaceuticals has announced the presentation of new scientific findings from its ongoing...
Innoviva and Dr. Reddy’s Expand Global Access to XACDURO®
WALTHAM, Mass., June 16, 2026 Innoviva Specialty Therapeutics announced an exclusive distribution and licensing agreement with Dr. Reddy’s Laboratories...
Advertisement
